Overview

Mineralocorticoid Use in COVID-19 Patients

Status:
Completed

Trial end date:
2022-06-20

Target enrollment:

Participant gender:

Summary

There is a considerable variability in aldosterone levels between individuals, and this may explain the wide variability in disease severity among those infected so we designed a pilot study to test for the safety and efficacy of fludrocortisone addition to standard of care in hospitalised COVID-19 patients.

Phase:

Phase 3

Details

Lead Sponsor:

Ain Shams University

Treatments:

Fludrocortisone